-+ 0.00%
-+ 0.00%
-+ 0.00%

MAHZI THERAPEUTICS ANNOUNCES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR MZ-1866 INVESTIGATIONAL THERAPY FOR PITT HOPKINS SYNDROME

Reuters·08/25/2026 14:00:38

Please log in to view news